School of Medicine

Research at Washington University School of Medicine in St. Louis has identified immune signaling molecules that are essential for activating neurons in the skin to cause chronic itching.

Scientists at the School of Medicine have converted skin cells from healthy adults directly into motor neurons without going through a stem cell state.

The TL1 Translational Sciences Postdoctoral Program is recruiting postdoctoral researchers to fill training grant slots under the Clinical Translational Science Awards. Funding is available to trainees.

Matthew A. Ciorba, MD, of the Division of Gastroenterology at Washington University School of Medicine in St. Louis, has been named chief of the division’s Inflammatory Bowel Disease Program.

New research from the School of Medicine in St. Louis and the University of California San Diego School of Medicine shows that the Zika virus can kill brain cancer stem cells, the kind of cells most resistant to standard treatments.

Sean J. English, MD, an assistant professor of surgery at Washington University School of Medicine in St. Louis, has been named the 2017 Wylie Scholar by Vascular Cures, a nonprofit organization that works to advance research in vascular disease.

Washington University in St. Louis will host a series of programs in early October featuring David J. Morris, a leading authority on post-traumatic stress disorder (PTSD). Morris will be joined by other local experts to examine the devastating effects of PTSD on society, as well as to discuss current therapies.

The School of Medicine has received a $46 million grant from the National Institutes of Health (NIH) to support research aimed at translating scientific and clinical discoveries into new diagnostics and therapeutics, and to more rapidly apply research findings to improve health.

During the past fiscal year, the Washington University in St. Louis Office of Technology Management reported a number of record figures as a result of the innovative technologies developed by university faculty.

Jeffrey I. Gordon, MD, the Dr. Robert J. Glaser Distinguished University Professor at Washington University School of Medicine in St. Louis, has received the 2017 Jacobæus Prize from the Novo Nordisk Foundation for his role as the founding father of gut microbiome research.